Federal Regulations

After Congress passes a law, federal agencies write the detailed rules that make it real. Each rulemaking project gets a — and while a rule is proposed, anyone can comment on it.

12,931

rulemaking dockets

4,709

open for public comment

You can weigh in on these right now

Showing 30 of 12,931 dockets

Rulemaking

NOAA

Open for Comments

NOAA-NMFS-2026-1354

Magnuson-Stevens Act Provisions; Fisheries Off West Coast States; Pacific Coast Groundfish Fishery; Pacific Coast Groundfish Fishery Management Plan; Amendment 38; 2027-28 Biennial Specifications and Management Measures

3 docsNo comments

Comments due Sep 20, 2026

Nonrulemaking

FRA

Open for Comments

FRA-2021-0054

Short-Line Railroad Seeks More Time to Keep Using Existing Stenciling on Cars

8 docs1 comment

Comments due Jun 30, 2026

Nonrulemaking

CNCS

Open for Comments

CNCS-2026-0199

AmeriCorps Seeks Public Comment to Renew Application Forms for Multiple Programs

3 docsNo comments

Comments due Aug 12, 2026

Nonrulemaking

FRA

FRA-2026-1948

Keokuk Junction Railway

1 docNo comments

Nonrulemaking

CNCS

Open for Comments

CNCS-2026-0298

AmeriCorps Seeks Public Comment to Renew Paperwork for President’s Volunteer Service Award

2 docsNo comments

Comments due Sep 19, 2026

Nonrulemaking

FDA

FDA-2026-H-7893

DAB Civil Money Penalty; Jennifer Grocery LLC d/b/a Jennifer Grocery

1 docNo comments

Rulemaking

ACF

ACF-2026-0529

HHS proposes cutting outdated rules to streamline child support programs

2 docs31 comments

Nonrulemaking

FDA

Open for Comments

FDA-2025-P-2162

Requests that absent new peer-reviewed studies or otherwise robust scientific or clinical evidence warranting such action, FDA take no action that would reduce patient access to mifepristone and/or increase the burdens associated with prescribing or dispensing mifepristone.

12 docs120 comments

Nonrulemaking

FDA

Open for Comments

FDA-2025-P-1576

Request that the FDA remove the Mifepristone REMS Program, including but not limited to the Prescriber Certification, Pharmacy Certification, and Patient Agreement form

23 docs155 comments

Nonrulemaking

FDA

FDA-2026-H-4160

DAB Civil Money Penalty; 2ND-XNG LLC d/b/a 2ND-XNG; CLOSED 7/21/2026

1 docNo comments

Nonrulemaking

FDA

Open for Comments

FDA-2025-P-0701

Request that the FDA classify and regulate NarxCare, a proprietary risk-scoring algorithm used in Prescription Drug Monitoring Programs (PDMPs), as a Software as a Medical Device (SaMD)

14 docs1.5K comments

Nonrulemaking

FDA

Open for Comments

FDA-2025-P-0377

Request that FDA remove the Mifepristone Shared System REMS Program, including but not limited to the three ETASU requiring prescriber certification, pharmacy certification, and a patient agreement form

10 docs247 comments

Nonrulemaking

FDA

FDA-2026-H-7859

DAB Civil Money Penalty; Infinity Trading Group, Inc. d/b/a 7-Eleven 35652B / BP

1 docNo comments

Nonrulemaking

FDA

FDA-2026-H-5945

DAB Civil Money Penalty; VI Retail Inc. d/b/a Vashon Market Fresh IGA; CLOSED 07/21/2026

1 docNo comments

Nonrulemaking

FAA

Open for Comments

FAA-2026-8453

Monday Consulting and Contractor LLC DBA BluSky Ag - Exemption/Rulemaking

2 docsNo comments

Nonrulemaking

HUD

HUD-2026-0826

HUD Seeks Info on U.S.-Made Building Products for Federally Funded Housing Projects

1 doc136 comments

Nonrulemaking

FDA

Open for Comments

FDA-2026-P-7183

Requests that the FDA declare that the drug product, Dexmethylphenidate Hydrochloride Tablets 7.5 mg is suitable for submission in an Abbreviated New Drug Application.

7 docsNo comments

Nonrulemaking

FDA

FDA-2026-H-4357

DAB Civil Money Penalty; Flint Fuel Mart Inc. d/b/a Mobil; CLOSED 7/20/2026

1 docNo comments

Nonrulemaking

IRS

Open for Comments

IRS-2026-0628

Alternative Method for Carrying Broker-Dealers to Comply with Certain Nonbank Trustee Rules (Notice 2026-32)

1 doc3 comments

Comments due Jul 21, 2026

Rulemaking

FDA

Open for Comments

FDA-2015-N-3534

Bulk Drug Substances That Can Be Used To Compound Drug Products in Accordance With Section 503A of the Federal Food, Drug, and Cosmetic Act

70 docs426 comments

Comments due Feb 22, 2050

Nonrulemaking

FDA

FDA-2026-H-2958

DAB Civil Money Penalty; Meta Labs LLC d/b/a Meta Smoke & Vape; CLOSED 7/20/2026

1 docNo comments

Nonrulemaking

FMC

FMC-2026-0034

Shipping company files amended complaint at Federal Maritime Commission over alleged unfair practices

14 docsNo comments

Nonrulemaking

FDA

FDA-2026-H-6646

DAB Civil Money Penalty; Qulin Operations LLC d/b/a Ron's; CLOSED 7/20/2026

1 docNo comments

Nonrulemaking

FMC

FMC-2026-0001

Federal Maritime Commission posts new shipping agreements for public review

18 docsNo comments

Rulemaking

DEA

DEA-2026-0793

DEA Proposes Clearer Rules for Manufacturer Quotas on Certain Controlled Drugs and Chemicals

1 doc47 comments

Nonrulemaking

FDA

Open for Comments

FDA-2011-N-0655

FDA Seeks Stakeholder Sign‑ups for Meetings on Reauthorizing Animal Generic Drug Fees

28 docs14 comments

Comments due Dec 2, 2027

Nonrulemaking

FDA

Open for Comments

FDA-2007-N-0221

Request for Comments on the Science and Technology Report; Establishment of Docket; Request for Comments

2 docs3 comments

Comments due Feb 5, 2008

Nonrulemaking

HHS

Open for Comments

HHS-OPHS-2018-0025

The Revised Common Rule's Exemption Category 5 Posting Rquirement

1 doc1 comment

Comments due Jul 1, 2032

Nonrulemaking

FAA

Open for Comments

FAA-2026-8289

B&L Chemicals Inc. - Exemption/Rulemaking

2 docsNo comments

Rulemaking

CMS

CMS-2026-0496

HHS Corrects Typos in 2027 ACA Payment and Benefit Rules

5 docs1K comments